+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

CRISPR Technology Market by Offering, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716152
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The CRISPR Technology Market grew from USD 3.25 billion in 2023 to USD 3.77 billion in 2024. It is expected to continue growing at a CAGR of 16.52%, reaching USD 9.49 billion by 2030.

CRISPR technology, a groundbreaking tool for gene editing, allows precise modifications to DNA, marking a new era in genetic research. The scope of CRISPR spans across various fields, including agriculture, where it's utilized for developing pest-resistant crops, and medicine, where it is pivotal in advancing gene therapy and treating genetic disorders like sickle cell anemia and cystic fibrosis. The necessity of CRISPR technology is driven by the need for more effective treatments and sustainable agricultural solutions, with applications in drug discovery, biotechnology, and even environmental conservation. The end-use scope encompasses pharmaceutical companies, research laboratories, agricultural industries, and academic institutions.

Market growth is influenced by factors such as increasing investment in biotechnology research, the growing prevalence of genetic disorders, and rising demand for genetically modified crops. Recent trends show a surge in collaboration between academic institutions and biotech firms, particularly in developing CRISPR-based therapeutics. Potential opportunities include untapped markets in personalized medicine and advancements in agricultural biotechnology. However, the market is constrained by ethical concerns regarding genetic editing, potential off-target effects, and regulatory challenges, which may slow down adoption in some regions.

Key areas for innovation include enhancing delivery mechanisms for CRISPR components, improving precision to minimize off-target effects, and developing regulatory frameworks that ensure ethical practices while fostering innovation. Continued research in human therapeutics and expanded applications in crop enhancement present significant growth avenues. Despite challenges, the CRISPR technology market exhibits a dynamic nature, characterized by rapid advancements and increasing acceptance. For optimal business growth, companies should invest in developing targeted therapies that cater to specific genetic conditions and collaborate with regulatory bodies to address ethical and safety concerns. Expanding partnerships with agricultural and pharmaceutical sectors can further enhance market penetration and acceptance.

Understanding Market Dynamics in the CRISPR Technology Market

The CRISPR Technology Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing need for new vaccines and treatments for genetic diseases
    • Increasing private and public investments in biotechnological and pharmaceutical sectors
  • Market Restraints
    • High cost and complexities involved in the government regulations
  • Market Opportunities
    • Advancements and improvements in CRISPR technology
    • Potential use of CRISPR technology in the agriculture sector
  • Market Challenges
    • Technical challenges and ethical concerns associated with CRISPR technology

Exploring Porter’s Five Forces for the CRISPR Technology Market

Porter’s Five Forces framework further strengthens the insights of the CRISPR Technology Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the CRISPR Technology Market

External macro-environmental factors deeply influence the performance of the CRISPR Technology Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the CRISPR Technology Market

The CRISPR Technology Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the CRISPR Technology Market

The CRISPR Technology Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Offering
    • Product
      • Enzymes
      • Guide RNA
      • Kits & Reagents
    • Services
      • Cell Line Engineering
      • gRNA Design & Vector Construction
      • Screening Services
  • Application
    • Agricultural
    • Biomedical
    • Industrial
  • End User
    • Academics & Government Research Institutes
    • Biotechnology Companies
      • Agricultural Companies
      • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Georgia
        • Illinois
        • Kentucky
        • Michigan
        • Mississippi
        • New Jersey
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
5.1.2. Restraints
5.1.2.1. High cost and complexities involved in the government regulations
5.1.3. Opportunities
5.1.3.1. Advancements and improvements in CRISPR technology
5.1.3.2. Potential use of CRISPR technology in the agriculture sector
5.1.4. Challenges
5.1.4.1. Technical challenges and ethical concerns associated with CRISPR technology
5.2. Market Segmentation Analysis
5.2.1. Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
5.2.2. Application: Proliferating use of CRISPR technology in the agricultural sector
5.2.3. End-User: Potential application of CRISPR technology in biotechnology companies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
5.5.1. CRISPR becoming a viable solution for bioenergy production
5.5.2. Expanding patent landscape for CRISPR technology
6. CRISPR Technology Market, by Offering
6.1. Introduction
6.2. Product
6.2.1. Enzymes
6.2.2. Guide RNA
6.2.3. Kits & Reagents
6.3. Services
6.3.1. Cell Line Engineering
6.3.2. gRNA Design & Vector Construction
6.3.3. Screening Services
7. CRISPR Technology Market, by Application
7.1. Introduction
7.2. Agricultural
7.3. Biomedical
7.4. Industrial
8. CRISPR Technology Market, by End User
8.1. Introduction
8.2. Academics & Government Research Institutes
8.3. Biotechnology Companies
8.3.1. Agricultural Companies
8.3.2. Pharmaceutical Companies
9. Americas CRISPR Technology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific CRISPR Technology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa CRISPR Technology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. RoslinCT Manufacture CRISPR-Based Therapy
12.3.2. First Human CRISPR Drug Moves Forward
12.3.3. ERS Genomics Limited (‘ERS’) Completes Licensing Agreement With Syngene International
12.3.4. Revvity's (RVTY) New Launch to Widen Access to Editing Technology
12.3.5. Pencil Biosciences Raises GBP 5.6 Million to Advance Gene Editing for Rare Diseases
12.3.6. Integrated DNA Technologies and Aldevron Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
12.3.7. Bedoukian Research Inc. Partners with Inscripta to Sustainably Develop and Manufacture Naturally Produced Ingredients
12.3.8. Scribe Announces Collaboration to Accelerate In Vivo CRISPR-Based Genetic Medicines
12.3.9. Vertex Teases Launch Plans for First Crispr Gene Editing Therapy Ahead of FDA Decision
12.3.10. Sherlock Biosciences to Acquire Sense Biodetection
12.3.11. Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics
List of Figures
FIGURE 1. CRISPR TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. CRISPR TECHNOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CRISPR TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CRISPR TECHNOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 47. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 48. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 79. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 80. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 82. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 85. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 86. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 97. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 98. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 100. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 133. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 134. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 153. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 158. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 159. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 164. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 165. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 170. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 171. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 188. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 189. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 191. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 206. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 207. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 212. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 213. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 218. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 219. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 221. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 243. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 261. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 278. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 279. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the CRISPR Technology market, which are profiled in this report, include:
  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Beam Therapeutics Inc.
  • Caribou Biosciences, Inc.
  • Cellectis S.A.
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • ERS Genomics Limited
  • Function Oncology
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group Ltd. by Revvity, Inc.
  • Inscripta, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Prime Medicine, Inc.
  • Scribe Therapeutics
  • Sherlock Biosciences, Inc.
  • Synthego Corporation
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • ToolGen, Inc.
  • TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
  • Twist Bioscience Corporation
  • Verve Therapeutics, Inc.

Methodology

Loading
LOADING...

Table Information